Oncology News
- ASCO 2024 ASCO 2024: Treating Myeloma Just Got More Complicated
- Std Dose or Baby TAM for Breast Cancer Prevention?
- Urticaria Linked to Higher Cancer Risk, Study Finds
- Does Dabrafenib-Trametinib Improve Survival in Melanoma?
- Better Access for a Few Patients Disrupts Care for Many
- ASCO 2024 Shorter Venetoclax Course Shows Promise for Some
- CAR-T Therapies May Be Linked to Secondary Tumors
- Time Warp: Fax Machines Still Common in Oncology Practice
- ASCO 2024 MUC-1 Vaccine Shows Notable Overall Survival Rates in BC
- Alert EMA Greenlights Four Drugs for Bladder and Other Cancers
- Phone-Based Support Improves Well-being After HSCT
- Rare Cutaneous Sarcoma More Common in Black Individuals
- ADA 2024 Hypercortisolism Prevalence High in Poorly Controlled T2D
- EHA 2024 Hemophilia: Marstacimab Sustains Long-Term Bleeding Decrease
- Alert FDA Approves Epcoritamab for R/R Follicular Lymphoma
- New Tools for Monitoring Multiple Myeloma
- Virtual Collaboration Boosts Rare Cancer Care in Europe
- Alert Europe Approves Fruzaqla for Metastatic Colorectal Cancer
- Cancer Drug Shortages Continue in the US, Survey Finds
- 5-mm Margin Excision Evaluated in Small Melanoma In Situ